ArticleFrontiers in immunology2025

Gemcitabine-cisplatin chemotherapy plus anti-PD-L1 therapy reinvigorates antitumor immune response by reprogramming the intrahepatic cholangiocarcinoma microenvironment.

Yang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.